3 Biotech Stocks With Powerful Catalysts – Including A Potential Acquisition Target
The biotech sector outperformed the S&P 500 last year – and further strong performance could lie ahead thanks in part to the tax break for…
The biotech sector outperformed the S&P 500 last year – and further strong performance could lie ahead thanks in part to the tax break for…